Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial. Slomski A. JAMA 2022;328:2003.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Slomski A. Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial. JAMA 2022;328:2003.
PMID: 36413233